Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
OFLOXACIN
Helsinn Birex Therapeutics Ltd
200 Milligram
Film Coated Tablet
2004-10-29
IRISH MEDICINES BOARD ACT 1995, AS AMENDED MEDICINAL PRODUCTS (CONTROL OF PLACING ON THE MARKET) REGULATIONS, 2007, AS AMENDED PA0915/008/001 Case No: 2086658 The Irish Medicines Board in exercise of the powers conferred on it by the above mentioned Regulations hereby grants to HELSINN BIREX THERAPEUTICS LTD DAMASTOWN, MULHUDDART, DUBLIN 15, IRELAND an authorisation, subject to the provisions of the said Regulations, in respect of the product BIRAVID 200 MG FILM-COATED TABLETS the particulars of which are set out in the attached Schedule. The authorisation is also subject to the general conditions as may be specified in the said Regulations as listed on the reverse of this document. This authorisation, unless previously revoked, shall continue in force from 30/07/2010. Signed on behalf of the Irish Medicines Board this ________________ A person authorised in that behalf by the said Board. IRISH MEDICINES BOARD ________________________________________________________________________________________________________________________ _Date Printed 30/07/2010_ _CRN 2086658_ _page number: 1_ PART II SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Biravid 200 mg Film-Coated tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet Contains 200mg ofloxacin Excipients: Each tablet contains 108.9mg lactose monohydrate. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablets {short term: tablets} White, round, film-coated tablets 11 mm in diameter, scored on both sides. One side of the tablet debossed ‘FXN’ on one side of the break-line and ‘200’ on the other side. The tablet can be divided into equal halves. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Ofloxacin is a synthetic 4-fluoroquinolone antibacterial agent. It is effective Read the complete document